GURINDER KAUR
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VISALIA, CA NPI 1548948854
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$241.83
- Category: General Payments
- Program years: PY2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $241.83 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.83 | 8 |
| Education | $45.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $81.11 | 2 |
| Amgen Inc. | $74.54 | 3 |
| Acerta Pharma LLC | $67.01 | 3 |
| E.R. Squibb & Sons, L.L.C. | $19.17 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $241.83 | 9 |
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078298025 | Janssen Biotech, Inc. | $45.00 | 06/11/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1078298151 | Janssen Biotech, Inc. | $36.11 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101343617 | E.R. Squibb & Sons, L.L.C. | $19.17 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104634703 | AstraZeneca Pharmaceuticals LP | $26.37 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105463855 | AstraZeneca Pharmaceuticals LP | $17.74 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105502464 | AstraZeneca Pharmaceuticals LP | $22.90 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115793593 | Amgen Inc. | $23.61 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115793630 | Amgen Inc. | $25.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117594891 | Amgen Inc. | $25.93 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.